SIA
MRNA icon

Sit Investment Associates’s Moderna MRNA Stock Holding History

Sit Investment Associates’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,409
Closed -$308K – 538
2024
Q4 		$308K Sell
7,409
-10,675
-59% -$510K 0.01% 447
2024
Q3 		$1.21M Buy
+18,084
New +$1.66M 0.03% 366

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sit Investment Associates's MRNA Position: Q1 2025 in Review

Sit Investment Associates sold out of Moderna (MRNA) in Q1 2025, closing a stake of 7,409 shares — an estimated $308K sold.

Sit Investment Associates first reported a position in MRNA in Q3 2024 and held it in 2 quarters. The position peaked at $1.21M in Q3 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Sit Investment Associates reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Sit Investment Associates sold 7,409 Moderna shares in Q1 2025, an estimated $308K.
  • Sit Investment Associates first reported a position in Moderna in Q3 2024 and held it in 2 quarters.
  • Sit Investment Associates's Moderna position peaked at $1.21M in Q3 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Sit Investment Associates's 13F filing for Q1 2025, filed 13 May 2025.